ArticleJournal of medicinal chemistry2021

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer.

Weiguo Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.